Gastroenterology COPY Flashcards
Definition Barretts
Classical > 3cm +/- Tongues
Prague Criteria for Barretts
C - degree circumferential disease
M - Maximal Barrett oesophagus segment length
For example, Barrett oesophagus extending circumferentially for 2 cm above the squamocolumnar junction but with tongues of Barrett oesophagus extending 5cm = C2M5.
Surveillance Barretts
Risk of progression to adenocarcinoma
- 5% if nil dysplasia; 3-5 year surveillance
- 7% Low-grade dysplasia, 6 monthly surveillance
7% High-grade dysplasia for surgery (or ablation if not fit for surgery)
SBP Diagnosis
Leuks > 500, with > 250 neutrophils
If predominantly lymphocytes > neutrophils, consider diagnosis of peritoneal carcinomatosis or Tb
Definition Hepatorenal syndrome
Relative lack of circulatory volume due to pooling in splanchnic blood flow
- Serum Cr > 133, without improvement with volume expansion & cessation of diuretics
- Urine Na < 20, no proteinurea
- Absence of other causes - new nephrotoxic drugs, shock
Types
Type 1; acute - x 2 baseline Cr over 2 weeks without improvement with volume expansion, diuretics or cessation of nephrotoxic drugs **expedite referral for transplant**
Type 2; slow and indolent progression with diuretic resistant ascites
HNPCC
Cancer with NO POLYPS- a patient with have a finding of colon cancer on scope, but the rest of the colon will be normal without polyps
Associated with microsatellite instability
Associated with MSH2 (60%) -“S for second & serious”, MLH1 (30%) gene mutation which are DNA mismatch repairs.
Most commonly cancer of the proximal colon
Associated with high risk of endometrial (80% lifetime risk), ovarian, stomach, small intestine, hepatobiliary, urinary tract, brain and skin cancers.
Kings criteria for Liver Transplant (Paracetamol Overdose)
“Acute PCM”
- Acidosis
- Prothrombin time > 100, INR > 6.5
- Cr > 300
- Mental state reduced, encephalopathy grade 3-4
Kings criteria for Liver Transplant (Not Paracetamol Overdose)
Prothrombin time > 100, INR > 6.5
OR, any 3 of;
- Non Hep A/B viral hepatitis, drug induced or indeterminate aetiology
- Time from jaundice to encephalopathy > 7 days
- Age < 10, > 40
- Prothrombin time > 50, INR > 3.5
Serum Bili > 17
Autoimmune Hepatitis
Commonly young females
Type 1
- associated with Autoimmune conditions (SLE, T1DM, UC, Coeliacs, Vasculitis)
- Anti-Smooth muscle Ab positive
Type 2
- Anti -Liver-kidney-microsomal Ab → Anti- LKM1
- High IgG (hypergammaglobinaemia)
Requires lifelong immunosuppression i.e. Pred or Azathioprine
Hep C treatment
If no cirrhosis, or pregnant - Maviret - “M for Mum”
- Glecaprevir (protease inhibitor)
- Pibrentasvir (NS5A inhibitor)
If cirrhotic - Epclusa “C for cirrhosis”
- Velpatasvir (NS5a inhibitor)
- Sofosbuvir (Nucleoside RNA polymerase inhibitors)
H.Pylori treatment
Triple therapy
Amoxicillin
Clarithromycin, or Metronidazole if sensitivity available
PPI
SALVAGE
- Levofloxacin triple therapy
Amoxicillin
Levofloxacin
PPI - Quadruple therapy
Bismuth salt
Tetracycline
Metronidazole
PPI - Rifabutin triple therapy
Amoxicillin
Rifabutin
PPI
CAG A = gastric
CAG B = duodenal
Proof of cure with C13 Urea breath test, faecal antigen or biopsy, at least 4 weeks after treatment. Serologic testing is not used to confirm H. pylori eradication because it can remain positive in the absence of active infection.
Leptin
Appetite suppressant and increases energy expenditure
At the arcuate nucleus of hypothalamus
- inhibits neurotransmitters; Neuropeptide Y & Agouti-related peptide
- Stimulates neurotransmitters; POMC a& MHC
Liver transplant criteria HCC
Single lesion 1- 5cm lesion
< 3 lesions, < 3cm in size
No metastatic disease
Contraindications to Liver transplant
- Morbid obesity > 40 BMI
- Current EtOH intake - abstinence 3-6 months
- Cardiopulmonary disease
Child Pugh Score
ABCDE
Albumin
Bilirubin
Coagulation
Drain or dullness (for ascites)
Encephalopathy
Crohns extra-intestinal manifestations that don’t correlate with disease activity
Pyoderma gangrenous
Primary sclerosing cholangitis
Small joint and axial arthritis
Uveitis
Crohns extra-intestinal manifestations that correlate with disease activity
Episcleritis
Large joint Arthritis
Erythema Nodosum
Apthous Ulcers
Crohns genetic predisposition
Nod2/CARD15 gene variants
- worse phenotype
- associated with early initial surgery due to stricturing disease and surgical recurrence in Crohn’s disease
pANCA negative, ASCA positive
Coeliac genetic predisposition
HLA DQ 2/8
Ustekinumab
Anti -IL 12 and 23 for psoriasis and associated peripheral arthropathy & inflammatory bowel disease
Serological markers IBD
- pANCA -, ASCA + = Crohns
- pANCA +, ASCA - = UC
Vedolizumab
Treatment IBD
Vedolizumab; alpha4, beta7 integrin receptor inhibitor
Prevents inflammatory cells translocating into gut
Gut specific - does not work for extra-intestinal manifestations
Safest, give to travellers to Tb endemic areas, elderly and cancer patients